Testing two experimental vaccines in healthy adults
This trial tests two new experimental vaccines to see if they are safe and how the body responds to them. It is only for healthy adults, so if you are generally well, you might be able to take part.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in good health overall
- You are between 18 and 49 years old, or between 60 and 84 years old
- Your body mass index (BMI) is between 18 and 35
- You have no history of cancer
- You do not have an autoimmune disease or a weakened immune system (acquired or from birth)
- You have never had Guillain-Barré syndrome
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental vaccine for respiratory syncytial virus (RSV), a common virus that can cause serious lung infections, especially in older adults. The study checks if the vaccine is safe and how the body responds to it.
This trial tests a new vaccine designed to help protect older adults from infections that can affect breathing. You might be able to join if you're in generally good health and meet the other requirements listed below.
This study tests an experimental vaccine to see if it is safe for healthy adults. The vaccine is made with mRNA technology and aims to protect against RSV, a common respiratory virus.
This early-phase study tests whether a new vaccine called V118E is safe and well-tolerated in healthy people. It is for adults who are in good health and have not recently had a pneumococcal infection.
This study tests a new flu vaccine to see how well it helps the body fight off the flu. It is for generally healthy adults aged 18 to 59 who have not had the flu recently.
This trial tests a new RSV vaccine in two phases. First, it will be given to healthy adults 18 and older to check safety. Then, it will be studied in adults 50 and older, including those with stable health conditions, to see if it helps protect against RSV, a common virus that can cause serious breathing problems in older people.
Hear when a new Lower Respiratory Tract Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.